BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23353843)

  • 1. The influence of rosuvastatin on liver microsomal CYP2C6 in hereditary hypertriglyceridemic rat.
    Vecera R; Zacharová A; Siller M; Matuskova Z; Skottová N; Anzenbacherová E; Anzenbacher P
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():48-52. PubMed ID: 23353843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats.
    Zachařová A; Siller M; Spičáková A; Anzenbacherová E; Skottová N; Anzenbacher P; Večeřa R
    Xenobiotica; 2012 Aug; 42(8):731-6. PubMed ID: 22360448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat.
    Večeřa R; Zachařová A; Orolin J; Strojil J; Skottová N; Anzenbacher P
    Biopharm Drug Dispos; 2011 Nov; 32(8):482-7. PubMed ID: 21968795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in hepatic expression of genes involved in lipid homeostasis between hereditary hypertriglyceridemic rats and healthy Wistar rats and in their response to dietary cholesterol.
    Orolin J; Vecera R; Markova I; Zacharova A; Anzenbacher P
    Food Chem Toxicol; 2009 Oct; 47(10):2624-30. PubMed ID: 19635522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
    Daniel WA; Haduch A; Syrek M; Boksa J
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
    Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
    Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.
    Sakaeda T; Fujino H; Komoto C; Kakumoto M; Jin JS; Iwaki K; Nishiguchi K; Nakamura T; Okamura N; Okumura K
    Pharm Res; 2006 Mar; 23(3):506-12. PubMed ID: 16388406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
    Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
    J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
    Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND; Liang K
    Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study.
    Haduch A; Ogórka T; Boksa J; Daniel WA
    Pharmacol Rep; 2005; 57(6):872-7. PubMed ID: 16382211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
    Shimizu T; Miura S; Tanigawa H; Kuwano T; Zhang B; Uehara Y; Saku K
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2246-53. PubMed ID: 25104799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rosuvastatin improves insulin sensitivity in overweight rats induced by high fat diet. Role of SIRT1 in adipose tissue].
    Valero-Muñoz M; Martín-Fernández B; Ballesteros S; Cachofeiro V; Lahera V; de Las Heras N
    Clin Investig Arterioscler; 2014; 26(4):161-7. PubMed ID: 24612843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase: pretranslational regulation and impact on microsomal drug activation.
    Chang TK; Bellward GD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1383-91. PubMed ID: 8819526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Schisandra chinensis (Wuweizi) constituents on the activity of hepatic microsomal CYP450 isozymes in rats detected by using a cocktail probe substrates method].
    Wang BL; Hu JP; Sheng L; Li Y
    Yao Xue Xue Bao; 2011 Aug; 46(8):922-7. PubMed ID: 22007516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
    Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
    Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
    Burma O; Onat E; Uysal A; Ilhan N; Erol D; Ozcan M; Sahna E
    Cardiovasc J Afr; 2014; 25(5):212-6. PubMed ID: 25629537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
    Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
    Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.